123 related articles for article (PubMed ID: 8746566)
1. Mapping of the linear site on the Fas/APO-1 molecule targeted by the prototypic anti-Fas mAb.
Fadeel B; Thorpe J; Chiodi F
Int Immunol; 1995 Dec; 7(12):1967-75. PubMed ID: 8746566
[TBL] [Abstract][Full Text] [Related]
2. Anti-Fas IgG1 antibodies recognizing the same epitope of Fas/APO-1 mediate different biological effects in vitro.
Fadeel B; Thorpe CJ; Yonehara S; Chiodi F
Int Immunol; 1997 Feb; 9(2):201-9. PubMed ID: 9040002
[TBL] [Abstract][Full Text] [Related]
3. A three-dimensional model of the Fas/APO-1 molecule: cross-reactivity of anti-Fas antibodies explained by structural mimicry of antigenic sites.
Fadeel B; Lindberg J; Achour A; Chiodi F
Int Immunol; 1998 Feb; 10(2):131-40. PubMed ID: 9533440
[TBL] [Abstract][Full Text] [Related]
4. VEINCTR-N, an immunogenic epitope of Fas (CD95/Apo-I), and soluble Fas enhance T-cell apoptosis in vitro. II. Functional analysis and possible implications in HIV-1 disease.
Silvestris F; Cafforio P; Tucci M; Del Prete A; Dammacco F
Mol Med; 2000 Jun; 6(6):509-26. PubMed ID: 10972087
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of an eight amino acid domain shared by Fas (CD95/Apo-I) and HIV-1 gp120. I. Structural and antigenic analysis.
Silvestris F; Cocco T; Cafforio P; Calvani N; Dammacco F
Mol Med; 2000 Jun; 6(6):494-508. PubMed ID: 10972086
[TBL] [Abstract][Full Text] [Related]
6. CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway.
Schattner EJ; Elkon KB; Yoo DH; Tumang J; Krammer PH; Crow MK; Friedman SM
J Exp Med; 1995 Nov; 182(5):1557-65. PubMed ID: 7595225
[TBL] [Abstract][Full Text] [Related]
7. Humanization and epitope mapping of neutralizing anti-human Fas ligand monoclonal antibodies: structural insights into Fas/Fas ligand interaction.
Nisihara T; Ushio Y; Higuchi H; Kayagaki N; Yamaguchi N; Soejima K; Matsuo S; Maeda H; Eda Y; Okumura K; Yagita H
J Immunol; 2001 Sep; 167(6):3266-75. PubMed ID: 11544314
[TBL] [Abstract][Full Text] [Related]
8. Cross-linking of Fas by antibodies to a peculiar domain of gp120 V3 loop can enhance T cell apoptosis in HIV-1-infected patients.
Silvestris F; Nagata S; Cafforio P; Silvestris N; Dammacco F
J Exp Med; 1996 Dec; 184(6):2287-300. PubMed ID: 8976184
[TBL] [Abstract][Full Text] [Related]
9. The conformational alteration of the mutated extracellular domain of Fas in an adult T cell leukemia cell line.
Maeda T; Nakayama S; Yamada Y; Sugahara K; Isomoto H; Tawara M; Yamasaki R; Onimaru Y; Matsushita T; Ohzono Y; Kamihira S
Biochem Biophys Res Commun; 2002 Sep; 296(5):1251-6. PubMed ID: 12207908
[TBL] [Abstract][Full Text] [Related]
10. Regulation of apoptosis and T cell activation by Fas-specific mAb.
Alderson MR; Tough TW; Braddy S; Davis-Smith T; Roux E; Schooley K; Miller RE; Lynch DH
Int Immunol; 1994 Nov; 6(11):1799-806. PubMed ID: 7532432
[TBL] [Abstract][Full Text] [Related]
11. Functional consequences of APO-1/Fas (CD95) antigen expression by normal and neoplastic hematopoietic cells.
Robertson MJ; Manley TJ; Pichert G; Cameron C; Cochran KJ; Levine H; Ritz J
Leuk Lymphoma; 1995 Mar; 17(1-2):51-61. PubMed ID: 7539660
[TBL] [Abstract][Full Text] [Related]
12. Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen.
Oehm A; Behrmann I; Falk W; Pawlita M; Maier G; Klas C; Li-Weber M; Richards S; Dhein J; Trauth BC
J Biol Chem; 1992 May; 267(15):10709-15. PubMed ID: 1375228
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis in a Fas-resistant, T-cell receptor-sensitive human leukaemic T-cell clone.
Delehanty LL; Payne JA; Farrow SN; Brown R; Champion BR
Immunology; 1997 Mar; 90(3):383-7. PubMed ID: 9155645
[TBL] [Abstract][Full Text] [Related]
14. Fas gene mutation in the progression of adult T cell leukemia.
Maeda T; Yamada Y; Moriuchi R; Sugahara K; Tsuruda K; Joh T; Atogami S; Tsukasaki K; Tomonaga M; Kamihira S
J Exp Med; 1999 Apr; 189(7):1063-71. PubMed ID: 10190897
[TBL] [Abstract][Full Text] [Related]
15. Anti-Fas antibodies induce cytolysis and apoptosis in cultured human mesangial cells.
González-Cuadrado S; López-Armada MJ; Gómez-Guerrero C; Subirá D; Garcia-Sahuquillo A; Ortiz-Gonzalez A; Neilson EG; Egido J; Ortiz A
Kidney Int; 1996 Apr; 49(4):1064-70. PubMed ID: 8691726
[TBL] [Abstract][Full Text] [Related]
16. NF-kappaB regulates Fas/APO-1/CD95- and TCR- mediated apoptosis of T lymphocytes.
Dudley E; Hornung F; Zheng L; Scherer D; Ballard D; Lenardo M
Eur J Immunol; 1999 Mar; 29(3):878-86. PubMed ID: 10092091
[TBL] [Abstract][Full Text] [Related]
17. Epitopes and functional responses defined by a panel of anti-Fas (CD95) monoclonal antibodies.
Komada Y; Inaba H; Li QS; Azuma E; Zhou YW; Yamamoto H; Sakurai M
Hybridoma; 1999 Oct; 18(5):391-8. PubMed ID: 10600025
[TBL] [Abstract][Full Text] [Related]
18. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95).
Dhein J; Walczak H; Bäumler C; Debatin KM; Krammer PH
Nature; 1995 Feb; 373(6513):438-41. PubMed ID: 7530335
[TBL] [Abstract][Full Text] [Related]
19. Release of preformed Fas ligand in soluble form is the major factor for activation-induced death of Jurkat T cells.
Martínez-Lorenzo MJ; Alava MA; Anel A; Piñeiro A; Naval J
Immunology; 1996 Dec; 89(4):511-7. PubMed ID: 9014814
[TBL] [Abstract][Full Text] [Related]
20. On the role and significance of Fas (Apo-1/CD95) ligand (FasL) expression in immune privileged tissues and cancer cells using multiple myeloma as a model.
Greil R; Egle A; Villunger A
Leuk Lymphoma; 1998 Nov; 31(5-6):477-90. PubMed ID: 9922038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
